Introduction of human papillomavirus (HPV) vaccination in Sweden

A Tegnell; J Dillner; B Andrae

doi:10.2807/ese.14.06.19119-en

Rapid communications Open Access

Like 0

Download

Introduction of human papillomavirus (HPV) vaccination in Sweden
A Tegnell¹ , J Dillner² , B Andrae³
View Affiliations Hide Affiliations

Affiliations: ¹ The National Board of Health and Welfare (Socialstyrelsen), Stockholm, Sweden ² University Hospital MAS (Universitetssjukhuset MAS), Malmö, Sweden ³ Cervical Cancer Prevention Working Group, Swedish Society of Obstetrics and Gynaecology, Stockholm, Sweden

Correspondence:
A Tegnell
Anders.Tegnell socialstyrelsen.se
View Citation Hide Citation

Citation style for this article: Tegnell A, Dillner J, Andrae B. Introduction of human papillomavirus (HPV) vaccination in Sweden. Euro Surveill. 2009;14(6):pii=19119. https://doi.org/10.2807/ese.14.06.19119-en Received: 09 Feb 2009

Abstract

The Swedish National Board of Health and Welfare (NBH) decided that a vaccine that protects against cervical cancer caused by human papillomavirus (HPV) should be included in the childhood vaccination directive as a nationwide-programme targeting 12-year-old girls from 2010 as a part of the school-health programme. Currently, vaccination of girls 13-18 years of age is covered by the public insurance. In this paper we describe the decision-making process behind the introduction of HPV vaccination in Sweden.